Back to Trades
O Andrew John
Chief Investment OfficerCIK 0002103158
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
O Andrew John, Chief Investment Officer, has filed 1 SEC report (2026), all concentrated in Polaryx Therapeutics, Inc. (PLYX), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Jan 29 | PLYX Polaryx Therapeutics, Inc. | O Andrew John | Chief Investment Officer | Other | $0 |
1 filing